Literature DB >> 16406260

The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization.

M Eijken1, M Koedam, M van Driel, C J Buurman, H A P Pols, J P T M van Leeuwen.   

Abstract

Glucocorticoids (GCs) exert profound effects on bone and are essential for human osteoblast differentiation. However, GCs are still interpreted as negative regulators of bone formation, mainly caused by the detrimental effects on bone after clinical use of GCs. In this paper we emphasize the importance of GCs for proper human osteoblast differentiation and matrix mineralization. We show that human osteoblast differentiation needs to be triggered by GCs in a specific time-window during the early stages of development. Exposure to GCs in the beginning of osteoblast development induces a dose dependent increase in alkaline phosphatase activity and matrix mineralization. GC-induced differentiation stimulated expression of genes involved in bone formation and suppressed genes that negatively regulate bone formation and mineralization. Furthermore we highlight the importance of local cortisol activation in osteoblasts by expression of 11beta-hydroxysteroid dehydrogenase 1 (11beta-HSD1).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406260     DOI: 10.1016/j.mce.2005.11.034

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  34 in total

1.  Systems biology towards life in silico: mathematics of the control of living cells.

Authors:  Hans V Westerhoff; Alexey Kolodkin; Riaan Conradie; Stephen J Wilkinson; Frank J Bruggeman; Klaas Krab; Jan H van Schuppen; Hanna Hardin; Barbara M Bakker; Martijn J Moné; Katja N Rybakova; Marco Eijken; Hans J P van Leeuwen; Jacky L Snoep
Journal:  J Math Biol       Date:  2008-02-16       Impact factor: 2.259

2.  Ultrastructural characteristics of glucocorticoid-induced osteoporosis.

Authors:  B Bouvard; M Audran; E Legrand; D Chappard
Journal:  Osteoporos Int       Date:  2009-06       Impact factor: 4.507

3.  Activin A suppresses osteoblast mineralization capacity by altering extracellular matrix (ECM) composition and impairing matrix vesicle (MV) production.

Authors:  Rodrigo D A M Alves; Marco Eijken; Karel Bezstarosti; Jeroen A A Demmers; Johannes P T M van Leeuwen
Journal:  Mol Cell Proteomics       Date:  2013-06-17       Impact factor: 5.911

Review 4.  Nanomedicine for safe healing of bone trauma: Opportunities and challenges.

Authors:  Shahed Behzadi; Gaurav A Luther; Mitchel B Harris; Omid C Farokhzad; Morteza Mahmoudi
Journal:  Biomaterials       Date:  2017-09-04       Impact factor: 12.479

5.  Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway.

Authors:  Andrea M Brum; Jeroen van de Peppel; Cindy S van der Leije; Marijke Schreuders-Koedam; Marco Eijken; Bram C J van der Eerden; Johannes P T M van Leeuwen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-29       Impact factor: 11.205

Review 6.  Glucocorticoid-induced osteoporosis: pathophysiology and therapy.

Authors:  E Canalis; G Mazziotti; A Giustina; J P Bilezikian
Journal:  Osteoporos Int       Date:  2007-06-14       Impact factor: 4.507

Review 7.  Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis.

Authors:  Lan-Juan Zhao; Hui Jiang; Christopher J Papasian; Dev Maulik; Betty Drees; James Hamilton; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2008-01       Impact factor: 6.741

8.  Dexamethasone induces osteogenesis via regulation of hedgehog signalling molecules in rat mesenchymal stem cells.

Authors:  Xiaoli Ma; Xueping Zhang; Yanfei Jia; Shanshan Zu; Shuyi Han; Dongjie Xiao; Haiji Sun; Yunshan Wang
Journal:  Int Orthop       Date:  2013-05-05       Impact factor: 3.075

9.  Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss.

Authors:  K Kaur; R Hardy; M M Ahasan; M Eijken; J P van Leeuwen; A Filer; A M Thomas; K Raza; C D Buckley; P M Stewart; E H Rabbitt; M Hewison; M S Cooper
Journal:  Ann Rheum Dis       Date:  2009-06-22       Impact factor: 19.103

Review 10.  Long-term therapy in COPD: any evidence of adverse effect on bone?

Authors:  Arnulf Langhammer; Siri Forsmo; Unni Syversen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.